Open AccessMolecular epidemiology of infections caused by group B Streptococcus in pregnant women and newborns, and development of preventive vaccines
Author(s) -
Vasilisa A. Vasilyeva,
Васильева Василиса Андреевна,
Elena Shipitsyna,
Шипицына Елена Васильевна,
Kira V. Shalepo,
Шалепо Кира Валентиновна,
Alevtina M. Savicheva,
Савичева Алевтина Михайловна
Publication year - 2018
Publication title -
žurnalʺ akušerstva i ženskihʺ boleznej
Language(s) - English
Resource type - Journals
eISSN - 1684-0461
pISSN - 1683-9366
DOI - 10.17816/jowd67562-73
Subject(s) - group b , serotype , epidemiology , immunogenicity , group a , medicine , molecular epidemiology , population , virulence , multilocus sequence typing , streptococcus agalactiae , streptococcus , immunology , microbiology and biotechnology , biology , genotype , genetics , environmental health , immune system , gene , bacteria
Hypothesis/aims of study. The present analysis was undertaken to summarize current knowledge about molecular properties of group B streptococci (GBS), emphasizing potential targets of vaccines against neonatal GBS infection.
Study design, materials, and methods. This review is based on articles published mainly in the last ten years.
Results. Epidemiological data on serotypes, multilocus sequence types, clonal complexes of GBS and their relationship are presented. Genetic events in GBS populations indicate significant obstacles to vaccine development. We described key properties of major GBS virulence factors, such as capsular polysaccharide, pili, and cell adhesion molecules, as well as results of experimental immunization on their basis.
Conclusion. The population of invasive GBS strains is molecularly and genetically heterogeneous, which complicates selection of vaccine targets. Capsular switching, a low level of immunogenicity and variability of population composition are the most important factors that necessitate the accumulation and monitoring of molecular epidemiological data.